Aug 13, 2026 04:01PM
Aug 13, 2026 04:01PM
Jul 7, 2026 04:30PM
Jul 7, 2026 04:30PM
Jun 24, 2026 04:05PM
Jun 24, 2026 04:05PM
Jun 4, 2026 08:00AM Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
May 15, 2026 06:00AM
Apr 15, 2026 06:06AM
Apr 15, 2026 06:05AM
Mar 27, 2026 09:49AM
Mar 27, 2026 08:00AM
Mar 27, 2026 08:00AM
Mar 9, 2026 06:00AM ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
Mar 2, 2026 06:37AM
Feb 10, 2026 08:00AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 21, 2026 08:00AM
Dec 29, 2025 08:00AM
Dec 29, 2025 08:00AM neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
Nov 10, 2025 06:00AM
Nov 4, 2025 08:00AM
Nov 3, 2025 02:23PM
Nov 3, 2025 02:23PM
Nov 3, 2025 07:45AM
Nov 3, 2025 07:45AM
Oct 8, 2025 08:00AM ARS Pharmaceuticals wins European patent challenge for neffy spray
Oct 8, 2025 08:00AM
Sep 29, 2025 04:06PM
Sep 29, 2025 04:05PM
Sep 19, 2025 08:01AM
Sep 19, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 13, 2025 07:00AM ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
Jul 18, 2025 09:26AM
Jul 18, 2025 09:25AM
May 14, 2025 07:00AM
May 7, 2025 08:00AM
May 7, 2025 08:00AM
May 2, 2025 08:00AM
Mar 20, 2025 07:00AM ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Mar 5, 2025 04:11PM
Mar 5, 2025 04:10PM
Mar 5, 2025 04:10PM
Feb 20, 2025 07:02PM
Feb 18, 2025 08:00AM
Jan 21, 2025 08:00AM
Jan 13, 2025 08:00AM ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
Jan 6, 2025 08:10AM

330,011 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All